Literature DB >> 16383211

Anxiety disorders in Parkinson's disease.

Irene H Richard1.   

Abstract

Anxiety disorders frequently occur in association with PD and may be important causes of morbidity. Actual prevalence rates are uncertain, but estimates suggest that up to 40% of patients with PD experience substantial anxiety. This percentage is greater than expected, particularly for an elderly population. In addition, the age at onset of anxiety in PD (and particularly panic disorder) is later than would be expected from current information regarding the natural course of anxiety disorders. Virtually all of the types of anxiety disorders have been described in PD, but panic disorder, GAD, and social phobia appear to be the ones most commonly encountered. Although most patients with motor fluctuations experience greater anxiety during the "off" phase, this is not a universal phenomenon. Anxiety frequently develops before the motor features do, suggesting that anxiety may not represent psychological and social difficulties in adapting to the illness but rather may be linked to specific neurobiologic processes that occur in PD. Most evidence points to disturbances in central noradrenergic systems, but other neurotransmitters (e.g., serotonin, dopamine) may be involved as well. Studies suggest that right hemispheric disturbances may be particularly important for the genesis of anxiety, especially panic and OCD. Whether antiparkinsonian medications themselves contribute to anxiety needs clarification. Anxiety and depression frequently coexist in PD. It remains to be determined whether anxiety in patients with PD reflects one of the following pathologies: (a) an underlying depressive mood disorder, (b) a particular subtype of depression (atypical depression, anxious or agitated depression), or (c) an independent psychiatric disturbance. The relationship between anxiety and dementia in PD is not clear, but current evidence suggests that cognitive dysfunction is not related to the presence of anxiety symptoms in this disorder. The optimal pharmacologic treatment for anxiety in patients with PD has not been established, nor has the effect of PD surgery on anxiety symptoms.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16383211

Source DB:  PubMed          Journal:  Adv Neurol        ISSN: 0091-3952


  33 in total

1.  Predictors of anxiety in early-stage Parkinson's disease - Results from the first two years of a prospective cohort study.

Authors:  Sonja Rutten; Peter M van der Ven; Daniel Weintraub; Gregory M Pontone; Albert F G Leentjens; Henk W Berendse; Ysbrand D van der Werf; Odile A van den Heuvel
Journal:  Parkinsonism Relat Disord       Date:  2017-07-05       Impact factor: 4.891

2.  A comparison of model-based (2D) and design-based (3D) stereological methods for estimating cell number in the substantia nigra pars compacta (SNpc) of the C57BL/6J mouse.

Authors:  Z C Baquet; D Williams; J Brody; R J Smeyne
Journal:  Neuroscience       Date:  2009-04-17       Impact factor: 3.590

3.  Research priorities in geriatric palliative care: nonpain symptoms.

Authors:  Sara Combs; Benzi M Kluger; Jean S Kutner
Journal:  J Palliat Med       Date:  2013-07-26       Impact factor: 2.947

Review 4.  Assessment and Management of Neuropsychiatric Symptoms in Parkinson's Disease.

Authors:  Christoph Mueller; Anto P Rajkumar; Yi Min Wan; Latha Velayudhan; Dominic Ffytche; Kallol Ray Chaudhuri; Dag Aarsland
Journal:  CNS Drugs       Date:  2018-07       Impact factor: 5.749

5.  Occurrence of depression and anxiety prior to Parkinson's disease.

Authors:  E L Jacob; N M Gatto; A Thompson; Y Bordelon; B Ritz
Journal:  Parkinsonism Relat Disord       Date:  2010-08-01       Impact factor: 4.891

6.  Depressive Symptoms are Frequent in Atypical Parkinsonian Disorders.

Authors:  Leonardo Almeida; Bilal Ahmed; Roger Walz; Sol De Jesus; Addie Patterson; Daniel Martinez-Ramirez; David Vaillancourt; Dawn Bowers; Herbert Ward; Michael S Okun; Nikolaus R McFarland
Journal:  Mov Disord Clin Pract       Date:  2016-06-24

7.  The bidirectional longitudinal relationship between insomnia, depression and anxiety in patients with early-stage, medication-naïve Parkinson's disease.

Authors:  Sonja Rutten; Chris Vriend; Ysbrand D van der Werf; Henk W Berendse; Daniel Weintraub; Odile A van den Heuvel
Journal:  Parkinsonism Relat Disord       Date:  2017-02-01       Impact factor: 4.891

Review 8.  Parkinson disease: an update.

Authors:  Steven J Frucht
Journal:  Neurologist       Date:  2004-07       Impact factor: 1.398

Review 9.  Neuropsychiatric symptoms in Parkinson's disease.

Authors:  Dag Aarsland; Laura Marsh; Anette Schrag
Journal:  Mov Disord       Date:  2009-11-15       Impact factor: 10.338

10.  Major life events and development of major depression in Parkinson's disease patients.

Authors:  N H Rod; Y Bordelon; A Thompson; E Marcotte; B Ritz
Journal:  Eur J Neurol       Date:  2012-10-30       Impact factor: 6.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.